Novartis net income climbs as drug sales grow
October 22, 2019 at 01:41 AM EDT
The Swiss drug giant singled out cardiovascular drug Entresto as well as psoriasis treatment Cosentyx as helping drive topline growth.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|